Atezolizumab with bevacizumab recommended for advanced or unresectable hepatocellular carcinoma
Results of an indirect comparison suggest that atezolizumab plus bevacizumab is more effective than lenvatinib.
Published
Please sign in or register for FREE
Sign in to OnMedica
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
See what other members have to say:
"Very useful, I have filled many gaps and gained practical knowledge."
"I feel now more confident in diagnosing the presented conditions. Really it is one of the best learning activities I have completed recently."
No comments yet.